PSI CRO AG

PSI CRO AG

Arzneimittelherstellung

The global CRO where clinical trials run on time.

Info

PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines. PSI’s global reach allows us to run clinical trials across multiple continents, in 50 countries around the world. PSI’s reputation is that of a 'no-nonsense' CRO focused on timely patient enrollment and project delivery. An exceptionally high repeat and referral business rates alongside low staff turnover are indicative of our commitment to be the best CRO in the world as measured by our clients and our employees. http://www.psi-cro.com

Website
http://www.psi-cro.com
Branche
Arzneimittelherstellung
Größe
1.001–5.000 Beschäftigte
Hauptsitz
Zug
Art
Privatunternehmen
Gegründet
1995
Spezialgebiete
Number One Patient Enrollment CRO, Clinical Research, Clinical Trials, Oncology, Hematology, Multiple Sclerosis, Infectious Diseases, Patient Enrollment, Phase 2 , Phase 3, Pivotal Trials, Global Clinical Trials und Full-Service Clinical Trials

Orte

Beschäftigte von PSI CRO AG

Updates

  • Unternehmensseite von PSI CRO AG anzeigen, Grafik

    225.085 Follower:innen

    Our PSI Hungary team recently gathered for their annual team-building event, providing a fantastic opportunity to connect with one another and brainstorm ways to foster our unwavering dedication to on-time clinical trial delivery. Our Budapest office has rapidly grown, with many new staff members joining in a short period. This growth meant that several colleagues hadn’t yet met in person or learned about each other's roles. We are fortunate to have a diverse blend of cultures represented in our office. In this constantly evolving world, our primary focus remains on what truly matters: our team. We are committed to fostering an inclusive culture where employees feel safe expressing their cultural identities. We aim to offer ample opportunities for team members to connect and build stronger relationships. We strongly believe in the power of team spirit. Events like this provide a fun and engaging way to work together while fostering collaboration and trust. Whether participating in playful tasks or navigating challenging situations, these moments of bonding outside business hours help us build a more efficient, cohesive, and empowered team. #PSIProud

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • PSI CRO AG hat dies direkt geteilt

    Profil von Jason Lake anzeigen, Grafik

    Physician Leader Transforming Healthcare Through Clinical Excellence & Innovation ► Aligning Stakeholders to Achieve Optimal Patient Care ► Committed to Enhancing Patient Outcomes & Improving Lives Globally

    “Being a Teammate” – One of PSI’s core values that deeply resonated with me as I recently began my journey with PSI CRO AG. Naturally, like anyone joining a new company, I was curious to see how this value is brought to life. Last week in Barcelona, at the Annual Medical Monitor Meeting, I found my answer. What stood out was the open exchange of ideas, unwavering support, and genuine collaboration among colleagues. It reinforced for me that, no matter the distance between us, when we work together, we accomplish more than we ever could as individuals. By continuing to prioritize mutual respect and global collaboration, I’m confident we’ll deliver innovative solutions and the high-quality outcomes our clients and patients expect from a top-tier CRO. #PSIProud

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von PSI CRO AG anzeigen, Grafik

    225.085 Follower:innen

    PSI is proud to support Vicore Pharma AB in executing the Phase 2b ASPIRE trial, drawing on our expertise in IPF pivotal studies. Learn more about our collaboration at the link below -->

    Unternehmensseite von Vicore Pharma AB anzeigen, Grafik

    4.738 Follower:innen

    We are thrilled to announce the initiation of the global, randomized Phase 2b ASPIRE trial, a pivotal step forward in our ongoing efforts to develop innovative treatments for idiopathic pulmonary fibrosis (#IPF). It is especially fitting that we are launching this important trial during Pulmonary Fibrosis Awareness Month, highlighting our dedication to raising awareness and finding solutions for these debilitating diseases. Our collaboration with PSI CRO AG is central to this undertaking, bringing together our shared expertise and commitment to making a difference in the lives of patients affected by IPF. You can find more information on the trial here: https://lnkd.in/e47PThKP #PFMonth #PulmonaryFibrosisAwarenessMonth #BlueUp4PF #clincialresearch #buloxibutid #Vicore

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden

Ähnliche Seiten